ZBTB9 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.93609581092369E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.45840000004483E-06 |
Normal-vs-Stage2 |
5.31570000239512E-08 |
Normal-vs-Stage3 |
5.05709918385833E-11 |
Normal-vs-Stage4 |
2.57700527583893E-11 |
Stage1-vs-Stage2 |
6.918000E-03 |
Stage1-vs-Stage3 |
4.215500E-04 |
Stage1-vs-Stage4 |
5.5417000000002E-05 |
Stage2-vs-Stage3 |
9.269600E-01 |
Stage2-vs-Stage4 |
5.007200E-01 |
Stage3-vs-Stage4 |
3.610600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
3.15260040295584E-11 |
Normal-vs-AfricanAmerican |
7.55190000000239E-05 |
Normal-vs-Asian |
9.160600E-03 |
Caucasian-vs-AfricanAmerican |
7.693200E-01 |
Caucasian-vs-Asian |
5.826200E-01 |
AfricanAmerican-vs-Asian |
5.693800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.93134397363792E-12 |
Normal-vs-Female |
1.43669999996821E-06 |
Male-vs-Female |
1.099500E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.777400E-04 |
Normal-vs-Age(41-60Yrs) |
3.19040016627525E-10 |
Normal-vs-Age(61-80Yrs) |
1.16889999901559E-08 |
Normal-vs-Age(81-100Yrs) |
2.02739999999313E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.751600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.650600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.457200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.845600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.978250E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.289200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
4.945000E-01 |
Normal-vs-Grade 2 |
4.41610000000425E-05 |
Normal-vs-Grade 3 |
1.73228098532263E-12 |
Normal-vs-Grade 4 |
1.84985360363044E-12 |
Grade 1-vs-Grade 2 |
1.953180E-01 |
Grade 1-vs-Grade 3 |
1.798190E-03 |
Grade 1-vs-Grade 4 |
4.49430000000195E-05 |
Grade 2-vs-Grade 3 |
2.45740000004435E-06 |
Grade 2-vs-Grade 4 |
6.21359996788584E-09 |
Grade 3-vs-Grade 4 |
2.379800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
6.46319999999534E-05 |
Normal-vs-ccB subtype |
1.53449475348566E-11 |
ccA subtype-vs-ccB subtype |
2.16650000051111E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.05530029159695E-10 |
Normal-vs-N1 |
3.758200E-04 |
N0-vs-N1 |
3.240200E-01 |
|
|